Use of Diabetes-related, Liver-derived Secreted Protein in Diagnosis or Treatment of Type-2 Diabetes or Vascular Disorder
Disclosed is use of selenoprotein P in the diagnosis or treatment of type-2 diabetes or a vascular disorder. Specifically disclosed are: a method for detection of type-2 diabetes or a vascular disorder, comprising measuring selenoprotein P; a method for evaluation of the risk of being suffering from type-2 diabetes or a vascular disorder; a method for evaluation of the insulin resistance or blood glucose control in a subject; and a therapeutic agent for type-2 diabetes or a vascular disorder which is targeted to selenoprotein P.
>>You can download the summary data (PDF format) by clicking on the following image.
- Uses & Applications
- Diagnosis, R&D of new drugs
- Application/Publication No.
- WO/2008/013324 (31.01.2008)
If you have any questions or would like to apply for a license, we recommend that you do so promptly. You can contact us by e-mail by clicking on the "Contact Us" button at the top of the page.